Results 1 - 20 of 11,520 for All Library Resources
Sorted by:
Sorted by:
Date-oldestOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
- Digital Resources/Online E-Resources (2,123)
- Peer-reviewed Journals (1,776)
Refined by:
subject:
Covid-19
Clinical Trials
Clinical Trials
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
![Recent advances in influenza vaccines [version 1; peer review: 2 approved]](../images/pixel.png){kind=tracking}
Material Type: Article
|
|
Recent advances in influenza vaccines [version 1; peer review: 2 approved]F1000 research, 2020, Vol.9, p.305 [Peer Reviewed Journal]Copyright: © 2020 Pawelec G and McElhaney J ;Copyright: © 2020 Pawelec G and McElhaney J. ;Copyright: © 2020 Pawelec G and McElhaney J. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright: © 2020 Pawelec G and McElhaney J 2020 ;ISSN: 2046-1402 ;EISSN: 2046-1402 ;DOI: 10.12688/f1000research.22611.1 ;PMID: 32399192Full text available |
| 2 |
Material Type: Article
|
|
The Recent Progress and Applications of Digital Technologies in Healthcare: A ReviewInternational journal of telemedicine and applications, 2020, Vol.2020, p.8830200-18 [Peer Reviewed Journal]Copyright © 2020 Maksut Senbekov et al. ;COPYRIGHT 2020 Hindawi Limited ;Copyright © 2020 Maksut Senbekov et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 ;Copyright © 2020 Maksut Senbekov et al. 2020 ;ISSN: 1687-6415 ;EISSN: 1687-6423 ;DOI: 10.1155/2020/8830200 ;PMID: 33343657Full text available |
| 3 |
Material Type: Article
|
|
COVID-19 vaccines: breaking record times to first-in-human trialsnpj vaccines, 2020, Vol.5 (1), p.34-34, Article 34 [Peer Reviewed Journal]The Author(s) 2020. ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2059-0105 ;EISSN: 2059-0105 ;DOI: 10.1038/s41541-020-0188-3 ;PMID: 32377399Full text available |
| 4 |
Material Type: Article
|
|
The Landscape of Emerging Randomized Clinical Trial Evidence for COVID-19 Disease Stages: A Systematic Review of Global Trial RegistriesInfection and drug resistance, 2020-01, Vol.13, p.4577-4587 [Peer Reviewed Journal]2020 Dillman et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Dillman et al. 2020 Dillman et al. ;ISSN: 1178-6973 ;EISSN: 1178-6973 ;DOI: 10.2147/IDR.S288399 ;PMID: 33376364Full text available |
| 5 |
Material Type: Article
|
|
Novel corona virus infection: a dermatologist's perspectivePigment international (Online), 2020-01, Vol.7 (1), p.5-11 [Peer Reviewed Journal]COPYRIGHT 2020 Pigmentary Disorders Society (PDS), India ;COPYRIGHT 2020 Medknow Publications and Media Pvt. Ltd. ;2020. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2349-5847 ;EISSN: 2349-5847 ;DOI: 10.4103/Pigmentinternational.Pigmentinternational_35_20Full text available |
| 6 |
Material Type: Article
|
|
COVID-19 Clinical Trials Registered Worldwide for Drug Intervention: An Overview and Characteristic AnalysisDrug design, development and therapy, 2020-01, Vol.14, p.5097-5108 [Peer Reviewed Journal]2020 Wang et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Wang et al. 2020 Wang et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S281700 ;PMID: 33239868Full text available |
| 7 |
Material Type: Article
|
|
Ethical review of patient safety and public health in EU clinical trials legislation: impact of COVID-19 pandemicRomanian journal of morphology and embryology, 2020-01, Vol.61 (1), p.277-281Copyright © 2020, Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest 2019 ;ISSN: 1220-0522 ;EISSN: 2066-8279 ;DOI: 10.47162/RJME.61.1.34 ;PMID: 32747923Full text available |
| 8 |
Material Type: Article
|
|
Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and ImplicationsInfection and drug resistance, 2020-01, Vol.13, p.4673-4695 [Peer Reviewed Journal]2020 Abubakar et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Abubakar et al. 2020 Abubakar et al. ;ISSN: 1178-6973 ;EISSN: 1178-6973 ;DOI: 10.2147/IDR.S289037 ;PMID: 33402839Full text available |
| 9 |
Material Type: Article
|
|
To Act.......or to wait for the evidence: Ethics in the time of covid-19Indian journal of rheumatology, 2020-01, Vol.15 (1), p.3-4 [Peer Reviewed Journal]COPYRIGHT 2020 Indian Rheumatology Association ;COPYRIGHT 2020 Medknow Publications and Media Pvt. Ltd. ;ISSN: 0973-3698 ;EISSN: 0973-3701 ;DOI: 10.4103/injr.injr_53_20Full text available |
| 10 |
Material Type: Article
|
|
Retraction of COVID-19 Pharmacoepidemiology Research Could Have Been Avoided by Effective Use of Reporting GuidelinesClinical epidemiology, 2020-01, Vol.12, p.1403-1420 [Peer Reviewed Journal]2020 Benchimol et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Benchimol et al. 2020 Benchimol et al. ;ISSN: 1179-1349 ;EISSN: 1179-1349 ;DOI: 10.2147/clep.s288677 ;PMID: 33376409Full text available |
| 11 |
Material Type: Article
|
|
The Current Recommended Drugs and Strategies for the Treatment of Coronavirus Disease (COVID-19)Therapeutics and clinical risk management, 2020-01, Vol.16, p.933-946 [Peer Reviewed Journal]2020 Sheikhpour. ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Sheikhpour. 2020 Sheikhpour. ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S262936 ;PMID: 33116543Full text available |
| 12 |
Material Type: Article
|
|
The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days [version 2; peer review: 2 approved]F1000 research, 2020-01, Vol.9, p.1193 [Peer Reviewed Journal]Copyright: © 2020 Janiaud P et al. ;Copyright: © 2020 Janiaud P et al. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright: © 2020 Janiaud P et al. 2020 ;ISSN: 2046-1402 ;EISSN: 2046-1402 ;DOI: 10.12688/f1000research.26707.2 ;PMID: 33082937Full text available |
| 13 |
Material Type: Article
|
|
Repurposing Anti-Cancer Drugs for COVID-19 TreatmentDrug design, development and therapy, 2020-01, Vol.14, p.5045-5058 [Peer Reviewed Journal]2020 Borcherding et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Borcherding et al. 2020 Borcherding et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S282252 ;PMID: 33239864Full text available |
| 14 |
Material Type: Article
|
|
Study Design Characteristics and Pharmacological Mechanisms in International Clinical Trials Registry Platform: Registered Clinical Trials on Antiviral Drugs for COVID-19Drug design, development and therapy, 2020-01, Vol.14, p.3803-3813 [Peer Reviewed Journal]2020 Zhang et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Zhang et al. 2020 Zhang et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S272442 ;PMID: 32982184Full text available |
| 15 |
Material Type: Article
|
|
Coping with the COVID-19 Pandemic's Unique Challenges Associated with Medical Research: A Saudi Institution ApproachRisk management and healthcare policy, 2020-01, Vol.13, p.3173-3178 [Peer Reviewed Journal]2020 Almeharish et al. ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Almeharish et al. 2020 Almeharish et al. ;ISSN: 1179-1594 ;EISSN: 1179-1594 ;DOI: 10.2147/RMHP.S283582 ;PMID: 33408539Full text available |
| 16 |
Material Type: Newspaper Article
|
|
Vaccine up to three years awayNational post (Toronto), 2020-01-312020 Postmedia Network Inc. All rights reserved. ;ISSN: 1486-8008Digital Resources/Online E-Resources |
| 17 |
Material Type: Newspaper Article
|
|
Vaccine up to three years awayNational post (Toronto), 2020-01-312020 Postmedia Network Inc. All rights reserved. ;ISSN: 1486-8008Digital Resources/Online E-Resources |
| 18 |
Material Type: Newspaper Article
|
|
Three-year wait possible: HEALTH: Team at vaccines facility in preliminary stages of developing a prototypeChronicle-herald (Halifax, N.S.), 2020-02-012020 The Chronicle Herald (Halifax, NS). All rights reserved. ;ISSN: 0828-1807Digital Resources/Online E-Resources |
| 19 |
Material Type: Newsletter Article
|
|
Eighth NewsWatchThe Canadian Press, 20202020 The Canadian Press. All rights reserved.Digital Resources/Online E-Resources |
| 20 |
Material Type: Newsletter Article
|
|
BioCentury Publications, Inc.: COVID-19 update: Remdesivir readout in weeks; hospital-use diagnostic under development; antibodies advancingNews Bites - Private Companies, 2020Copyright News Bites Pty Ltd Feb 13, 2020Digital Resources/Online E-Resources |
Results 1 - 20 of 11,520 for All Library Resources
Sorted by:
Sorted by:
Date-oldestOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
- Digital Resources/Online E-Resources (2,123)
- Peer-reviewed Journals (1,776)
Refine My Results
Creation Date
- Before 2020 (1)
- 2020 To 2020 (5,611)
- 2021 To 2021 (3,526)
- 2022 To 2023 (2,286)
- After 2023 (99)
-
More options
New Records
Resource Type
- Newsletter Articles (7,449)
- Articles (2,104)
- Newspaper Articles (1,508)
- Web Resources (206)
- magazinearticle (172)
- Text Resources (47)
- Reports (31)
- Thesises (postgraduate) (1)
- Reviews (1)
- Audio (1)
-
More options
Subject
- Medical Research (11,445)
- Coronaviruses (9,355)
- Pandemics (3,959)
- Vaccines (3,161)
- Severe Acute Respiratory Syndrome Coronavirus 2 (3,158)
- Patients (2,326)
- Covid-19 Vaccines (2,175)
- R&d (2,158)
- Research & Development (2,158)
- Pharmaceutical Industry (1,845)
- Biotechnology Industry (1,737)
- Net Losses (1,602)
- Stockholders (1,598)
- Science & Technology (1,539)
- Earnings Per Share (1,489)
- Collaboration (1,416)
- Life Sciences & Biomedicine (1,364)
- Infections (1,325)
-
More options
Databases
- ProQuest Central (11,419)
- PubMed Central (1,192)
- DOAJ Directory of Open Access Journals (1,173)
- Coronavirus Research Database (1,114)
- ROAD: Directory of Open Access Scholarly Resources (1,033)
- GFMER Free Medical Journals (854)
- MEDLINE (837)
- Springer Nature OA/Free Journals (354)
- ProQuest One Psychology (305)
- HighWire Press (Free Journals) (168)
- Public Library of Science (PLoS) (112)
- Wiley-Blackwell Open Access Titles (73)
- BMJ Open Access Journals (64)
- Journals@Ovid Open Access Journal Collection Rolling (46)
- Taylor & Francis Open Access (46)
- DOVE Medical Press Journals (45)
- Cambridge Wholly Gold Open Access Journals (32)
- Freely Accessible Journals (27)
- SWEPUB Freely available online (26)
- Oxford Journals Open Access Collection (14)
-
More options
Language
- English (11,516)
- Japanese (87)
- Urdu (16)
- Portuguese (6)
- Spanish (4)
- Italian (1)
- French (1)
- Norwegian (1)
-
More options
Journal Title
- Asia News Monitor (124)
- Current Controlled Trials In Cardiovascular Medicine (86)
- Mint (79)
- New York Times (97)
- Plos One (96)
- Pr Newswire (135)
- The New York Times (88)
- The Wall Street Journal. Eastern Edition (131)
- The Washington Post (93)
- Trials (86)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||